Surasa Nagachinta, Belen Lopez Bouzo, Abi Judit Vazquez-Rios, Rafael Lopez, & Maria de la Fuente. (2020). Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics. MDPI AG.
Chicago Style (17th ed.) CitationSurasa Nagachinta, Belen Lopez Bouzo, Abi Judit Vazquez-Rios, Rafael Lopez, and Maria de la Fuente. Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer MiRNA Therapeutics. MDPI AG, 2020.
MLA (9th ed.) CitationSurasa Nagachinta, et al. Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer MiRNA Therapeutics. MDPI AG, 2020.
Warning: These citations may not always be 100% accurate.